CBAY

Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q1 2021 Results - Earnings Call Transcript

CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update

Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q4 2020 Results - Earnings Call Transcript

CymaBay Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update

CymaBay Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 25, 2021

CymaBay Therapeutics Announces Oral Late-Breaking Presentation of Positive Results from the ENHANCE Global Phase 3 Study Evaluating Seladelpar for Primary Biliary Cholangitis at The Liver Meeting® 2020

CymaBay Therapeutics to Present at Upcoming Investor Conferences